PPAR in obesity: Sex difference and estrogen involvement

PPAR Research

Volumn , Issue , 2010, Pages

  Yoon, Michung ^a  

^a Mokwon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROID;

BODY WEIGHT; GENE TARGETING; NONHUMAN; OBESITY; OVARIECTOMY; OVARY FUNCTION; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE;

EID: 77956859765     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/584296     Document Type: Review

References (101)

1. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
2. Beck F., Plummer S., Senior P. V., Byrne S., Green S., Brammar W. J., The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat Proceedings of the Royal Society B 1992 247 1319 83 87
3. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366
4. Aoyama T., Peters J. M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F. J., Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor (PPAR ) Journal of Biological Chemistry 1998 273 10 5678 5684
5. Auwerx J., Schoonjans K., Fruchart J.-C., Staels B., Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR Atherosclerosis 1996 124, supplement S29 S37
6. Hertz R., Bishara-Shieban J., Bar-Tana J., Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III Journal of Biological Chemistry 1995 270 22 13470 13475
7. Yan Z. H., Karam W. G., Staudinger J. L., Medvedev A., Ghanayem B. I., Jetten A. M., Regulation of peroxisome proliferator-activated receptor -induced transactivation by the nuclear orphan receptor TAK1/TR4 Journal of Biological Chemistry 1998 273 18 10948 10957
8. Costet P., Legendre C., Mor J., Edgar A., Galtier P., Pineau T., Peroxisome proliferator-activated receptor -isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis Journal of Biological Chemistry 1998 273 45 29577 29585
9. Chaput E., Saladin R., Silvestre M., Edgar A. D., Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight Biochemical and Biophysical Research Communications 2000 271 2 445 450
10. Guerre-Millo M., Gervois P., Rasp E., Madsen L., Poulain P., Derudas B., Herbert J.-M., Winegar D. A., Willson T. M., Fruchart J.-C., Berge R. K., Staels B., Peroxisome proliferator-activated receptor activators improve insulin sensitivity and reduce adiposity Journal of Biological Chemistry 2000 275 22 16638 16642
11. Mancini F. P., Lanni A., Sabatino L., Moreno M., Giannino A., Contaldo F., Colantuoni V., Goglia F., Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats FEBS Letters 2001 491 1-2 154 158
12. Mystkowski P., Schwartz M. W., Gonadal steroids and energy homeostasis in the leptin era Nutrition 2000 16 10 937 946
13. Wade G. N., Some effects of ovarian hormones on food intake and body weight in female rats Journal of Comparative and Physiological Psychology 1975 88 1 183 193
14. Tchernof A., Calles-Escandon J., Sites C. K., Poehlman E. T., Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy Coronary Artery Disease 1998 9 8 503 511
15. Geary N., Asarian L., Estradiol increases glucagon's satiating potency in ovariectomized rats American Journal of Physiology 2001 281 4 R1290 R1294
16. D'Eon T. M., Souza S. C., Aronovitz M., Obin M. S., Fried S. K., Greenberg A. S., Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways Journal of Biological Chemistry 2005 280 43 35983 35991
17. Shearer G. C., Joles J. A., Jones H. Jr., Walzem R. L., Kaysen G. A., Estrogen effects on triglyceride metabolism in analbuminemic rats Kidney International 2000 57 6 2268 2274
18. Shinoda M., Latour M. G., Lavoie J.-M., Effects of physical training on body composition and organ weights in ovariectomized and hyperestrogenic rats International Journal of Obesity 2002 26 3 335 343
19. Roesch D. M., Effects of selective estrogen receptor agonists on food intake and body weight gain in rats Physiology Behavior 2006 87 1 39 44
20. Yoon M., Jeong S., Nicol C. J., Lee H., Han M., Kim J.-J., Seo Y.-J., Ryu C., Oh G. T., Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism Experimental and Molecular Medicine 2002 34 6 481 488
21. Yoon M., Jeong S., Lee H., Han M., Kang J. H., Kim E. Y., Kim M., Oh G. T., Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice Biochemical and Biophysical Research Communications 2003 302 1 29 34
22. Jeong S., Kim M., Han M., Lee H., Ahn J., Kim M., Song Y.-H., Shin C., Nam K.-H., Kim T. W., Oh G. T., Yoon M., Fenofibrate prevents obesity and hypertriglyceridemia in low-ddensity lipoprotein receptor-null mice Metabolism 2004 53 5 607 613
23. Jeong S., Han M., Lee H., Kim M., Kim J., Nicol C. J., Kim B. H., Choi J. H., Nam K.-H., Oh G. T., Yoon M., Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice Metabolism 2004 53 10 1284 1289
24. Keller H., Givel F., Perroud M., Wahli W., Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements Molecular Endocrinology 1995 9 7 794 804
25. Nunez S. B., Medin J. A., Keller H., Ozato K., Wahli W., Segars J., Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen response element Recent Progress in Hormone Research 1995 50 1 409 415
26. Zhu Y., Kan L., Qi C., Kanwar Y. S., Yeldandi A. V., Rao M. S., Reddy J. K., Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR Journal of Biological Chemistry 2000 275 18 13510 13516
27. Nuez S. B., Medin J. A., Braissant O., Kemp L., Wahli W., Ozato K., Segars J. H., Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor Molecular and Cellular Endocrinology 1997 127 1 27 40
28. Tcherepanova I., Puigserver P., Norris J. D., Spiegelman B. M., McDonnell D. P., Modulation of estrogen receptor- transcriptional activity by the coactivator PGC-1 Journal of Biological Chemistry 2000 275 21 16302 16308
29. Boitier E., Gautier J.-C., Roberts R., Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease Comparative Hepatology 2003 2, article 3
30. Wierman M. E., Sex steroid effects at target tissues: mechanisms of action Advances in Physiology Education 2007 31 1 26 33
31. Bain D. L., Heneghan A. F., Connaghan-Jones K. D., Miura M. T., Nuclear receptor structure: implications for function Annual Review of Physiology 2007 69 201 220
32. Jeong S., Yoon M., Inhibition of the actions of peroxisome proliferator-activated receptor a on obesity by estrogen Obesity 2007 15 6 1430 1440
33. Yoon M., The role of PPAR in lipid metabolism and obesity: focusing on the effects of estrogen on PPAR actions Pharmacological Research 2009 60 151 159
34. Jenster G., Coactivators and corepressors as mediators of nuclear receptor function: an update Molecular and Cellular Endocrinology 1998 143 1-2 1 7
35. Glass C. K., Going nuclear in metabolic and cardiovascular disease Journal of Clinical Investigation 2006 116 3 556 560
36. Flamant F., Gauthier K., Samarut J., Thyroid hormones signaling is getting more complex: STORMs are coming Molecular Endocrinology 2007 21 2 321 333
37. Arpino G., Wiechmann L., Osborne C. K., Schiff R., Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance Endocrine Reviews 2008 29 2 217 233
38. Sher T., Yi H.-F., McBride O. W., Gonzalez F. J., cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 1993 32 21 5598 5604
39. Marx N., Duez H., Fruchart J.-C., Staels B., Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells Circulation Research 2004 94 9 1168 1178
40. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I. P., Delerive P., Fadel A., Chinetti G., Fruchart J.-C., Najib J., Maclouf J., Tedgui A., Activation of human aortic smooth-muscle cells is inhibited by PPAR but not by PPAR activators Nature 1998 393 6687 790 793
41. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M. G., Wahli W., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Molecular Endocrinology 1997 11 6 779 791
42. Berger J. P., Akiyama T. E., Meinke P. T., PPARs: therapeutic targets for metabolic disease Trends in Pharmacological Sciences 2005 26 5 244 251
43. Fivet C., Fruchart J.-C., Staels B., PPAR and PPAR dual agonists for the treatment of type 2 diabetes and the metabolic syndrome Current Opinion in Pharmacology 2006 6 6 606 614
44. Srivastava R. A. K., Jahagirdar R., Azhar S., Sharma S., Bisgaier C. L., Peroxisome proliferator-activated receptor- selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice Molecular and Cellular Biochemistry 2006 285 1-2 35 50
45. Wang S., Subramaniam A., Cawthorne M. A., Clapham J. C., Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle Diabetes, Obesity and Metabolism 2003 5 5 295 301
46. Cabrero., Alegret M., Snchez R. M., Adzet T., Laguna J. C., Vzquez M., Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes Diabetes 2001 50 8 1883 1890
47. Okamoto Y., Higashiyama H., Inoue H., Kanematsu M., Kinoshita M., Asano S., Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor- and- agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice Pathology International 2007 57 6 369 377
48. Jeong S., Yoon M., Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPAR in high fat diet-induced obese mice Experimental and Molecular Medicine 2009 41 6 397 405
49. Muoio D. M., Dohm G. L., Peripheral metabolic actions of leptin Best Practice Research: Clinical Endocrinology Metabolism 2002 16 4 653 666
50. Hines E. P., White S. S., Stanko J. P., Gibbs-Flournoy E. A., Lau C., Fenton S. E., Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life Molecular and Cellular Endocrinology 2009 304 1-2 97 105
51. Koh E. H., Kim M.-S., Park J.-Y., Kim H. S., Youn J.-Y., Park H.-S., Youn J. H., Lee K.-U., Peroxisome proliferator-activated receptor (PPAR)- activation prevents diabetes in OLETF rats: comparison with PPAR- activation Diabetes 2003 52 9 2331 2337
52. Lalloyer F., Vandewalle B., Percevault F., Torpier G., Kerr-Conte J., Oosterveer M., Paumelle R., Fruchart J.-C., Kuipers F., Pattou F., Fivet C., Staels B., Peroxisome proliferator-activated receptor improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets Diabetes 2006 55 6 1605 1613
53. Staels B., Maes M., Zambon A., Fibrates and future PPAR agonists in the treatment of cardiovascular disease Nature Clinical Practice Cardiovascular Medicine 2008 5 9 542 553
54. Klein-Hitpass L., Schorpp M., Wagner U., Ryffel G. U., An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells Cell 1986 46 7 1053 1061
55. Hall J. M., McDonnel D. P., The estrogen receptor -isoform (ER ) of the human estrogen receptor modulates ER transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens Endocrinology 1999 140 12 5566 5578
56. Katzenellenbogen B. S., Estrogen receptors: bioactivities and interactions with cell signaling pathways Biology of Reproduction 1996 54 2 287 293
57. Dieudonn M. N., Leneveu M. C., Giudicelli Y., Pecquery R., Evidence for functional estrogen receptors and in human adipose cells: regional specificities and regulation by estrogens American Journal of Physiology 2004 286 3 C655 C661
58. Barros R. P. A., Machado U. F., Warner M., Gustafsson J.-., Muscle GLUT4 regulation by estrogen receptors ER and ER Proceedings of the National Academy of Sciences of the United States of America 2006 103 5 1605 1608
59. Koehler K. F., Helguero L. A., Haldosn L.-A., Warner M., Gustafsson J.-., Reflections on the discovery and significance of estrogen receptor Endocrine Reviews 2005 26 3 465 478
60. Wiik A., Glenmark B., Ekman M., Esbjrnsson-Liljedahl M., Johansson O., Bodin K., Enmark E., Jansson E., Oestrogen receptor is expressed in adult human skeletal muscle both at the mRNA and protein level Acta Physiologica Scandinavica 2003 179 4 381 387
61. Nilsson S., Mkel S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.-., Mechanisms of estrogen action Physiological Reviews 2001 81 4 1535 1565
62. Bouchard C., Desprs J.-P., Maurige P., Genetic and nongenetic determinants of regional fat distribution Endocrine Reviews 1993 14 1 72 93
63. Sharp J. C., Copps J. C., Liu Q., Ryner L. N., Sebastian R. A., Zeng G. Q., Smith S., Niere J. O., Tomanek B., Sato M., Analysis of ovariectomy and estrogen effects on body composition in rats by X-ray and magnetic resonance imaging techniques Journal of Bone and Mineral Research 2000 15 1 138 146
64. Gray J. M., Wade G. N., Food intake, body weight, and adiposity in female rats: actions and interactions of progestins and antiestrogens American Journal of Physiology 1981 240 5 E474 E481
65. Leshner A., Collier G., The effects of gonadectomy on the sex differences in dietary self selection patterns and carcass compositions of rats Physiology Behavior 1973 11 5 671 676
66. Jones M. E. E., Thorburn A. W., Britt K. L., Hewitt K. N., Wreford N. G., Proietto J., Oz O. K., Leury B. J., Robertson K. M., Yao S., Simpson E. R., Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proceedings of the National Academy of Sciences of the United States of America 2000 97 23 12735 12740
67. Heine P. A., Taylor J. A., Iwamoto G. A., Lubahn D. B., Cooke P. S., Increased adipose tissue in male and female estrogen receptor- knockout mice Proceedings of the National Academy of Sciences of the United States of America 2000 97 23 12729 12734
68. Houpt K. A., Coren B., Hintz H. F., Hilderbrant J. E., Effect of sex and reproductive status on sucrose preference, food intake, and body weight of dogs Journal of the American Veterinary Medical Association 1979 174 10 1083 1085
69. Rosenblatt H., Dyrenfurth I., Ferin M., vande Wiele R. L., Food intake and the menstrual cycle in rhesus monkeys Physiology Behavior 1980 24 3 447 449
70. Geary N., Asarian L., Cyclic estradiol treatment normalizes body weight and test meal size in ovariectomized rats Physiology Behavior 1999 67 1 141 147
71. Liang Y.-Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M., Ouchi Y., Estrogen receptor is involved in the anorectic action of estrogen International Journal of Obesity and Related Metabolic Disorders 2002 26 8 1103 1109
72. Gasse C., Hense H.-W., Stieber J., Dring A., Liese A. D., Keil U., Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 19841995 Journal of Human Hypertension 2001 15 1 27 36
73. Barros R. P. A., Machado U. F., Gustafsson J.-A., Estrogen receptors: new players in diabetes mellitus Trends in Molecular Medicine 2006 12 9 425 431
74. Regitz-Zagrosek V., Lehmkuhl E., Mahmoodzadeh S., Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease Gender Medicine 2007 4 supplement B S162 S177
75. Shi H., Clegg D. J., Sex differences in the regulation of body weight Physiology Behavior 2009 97 199 204
76. Fruchart J. C., Brewer H. B. Jr., Leitersdorf E., Assmann G., Brochier M., Brown G., Calvo C., Carmena R., Ceska R., Loy-Soong W. C., Davignon J., Gotto A., Grundy S., Hamsten A., Keech A., Matsuzawa Y., Patch J. R., Paoletti R., Raslova K., Smirnov V., Steiner G., Thompson G., Zhu J. R., Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease American Journal of Cardiology 1998 81 7 912 917
77. Lupien P. J., Brun D., Gagne C., Moorjani S., Bielman P., Julien P., Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins Canadian Journal of Cardiology 1991 7 1 27 33
78. Rustan A. C., Christiansen E. N., Drevon C. A., Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed -3 and -6 fatty acids Biochemical Journal 1992 283 2 333 339
79. Skrede S., Bremer J., Berge R. K., Rustan A. C., Stimulation of fatty acid oxidation by a 3-thia fatty acid reduces triacylglycerol secretion in cultured rat hepatocytes Journal of Lipid Research 1994 35 8 1395 1404
80. Akiyama T. E., Nicol C. J., Fievet C., Staels B., Ward J. M., Auwerx J., Lee S. S. T., Gonzalez F. J., Peters J. M., Peroxisome proliferator-activated receptor- regulates lipid homeostasis, but is not associated with obesity. Studies with congenic mouse lines Journal of Biological Chemistry 2001 276 42 39088 39093
81. Schreyer S. A., Vick C., Lystig T. C., Mystkowski P., LeBoeuf R. C., LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice American Journal of Physiology 2002 282 E207 E214
82. Lake B. G., Mechanisms of hepatocarcinogenicity of peroxisome- proliferating drugs and chemicals Annual Review of Pharmacology and Toxicology 1995 35 483 507
83. Minnich A., Tian N., Byan L., Bilder G., A potent PPAR agonist stimulates mitochondrial fatty acid -oxidation in liver and skeletal muscle American Journal of Physiology 2001 280 2 E270 E279
84. Taghibiglou C., Carpentier A., Van Iderstine S. C., Chen B., Rudy D., Aiton A., Lewis G. F., Adeli K., Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model Journal of Biological Chemistry 2000 275 12 8416 8425
85. Siri P., Candela N., Zhang Y.-L., Ko C., Eusufzai S., Ginsberg H. N., Huang L.-S., Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance Journal of Biological Chemistry 2001 276 49 46064 46072
86. Shimizugawa T., Ono M., Shimamura M., Yoshida K., Ando Y., Koishi R., Ueda K., Inaba T., Minekura H., Kohama T., Furukawa H., ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase Journal of Biological Chemistry 2002 277 37 33742 33748
87. Peters J. M., Hennuyer N., Staels B., Fruchart J.-C., Fievet C., Gonzalez F. J., Auwerx J., Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor -deficient mice Journal of Biological Chemistry 1997 272 43 27307 27312
88. Staels B., Vu-Dac N., Kosykh V. A., Saladin R., Fruchart J.-C., Dallongeville J., Auwerx J., Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates Journal of Clinical Investigation 1995 95 2 705 712
89. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue Nature 1994 372 6505 425 432
90. Lee G.-H., Proenca R., Montez J. M., Carroll K. M., Darvishzadeh J. G., Lee J. I., Friedman J. M., Abnormal splicing of the leptin receptor in diabetic mice Nature 1996 379 6566 632 635
91. Kelly L. J., Vicario P. P., Thompson G. M., Candelore M. R., Doebber T. W., Ventre J., Wu M. S., Meurer R., Forrest M. J., Conner M. W., Cascieri M. A., Moller D. E., Peroxisome proliferator-activated receptors and mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression Endocrinology 1998 139 12 4920 4927
92. Tsuboyama-Kasaoka N., Takahashi M., Kim H., Ezaki O., Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice Biochemical and Biophysical Research Communications 1999 257 3 879 885
93. Wang X., Kilgore M. W., Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells Molecular and Cellular Endocrinology 2002 194 1-2 123 133
94. Wade G. N., Gray J. M., Bartness T. J., Gonadal influences on adiposity International Journal of Obesity 1985 9 1 83 92
95. Asarian L., Geary N., Modulation of appetite by gonadal steroid hormones Philosophical Transactions of the Royal Society of London. Series B 2006 361 1471 1251 1263
96. Tchernof A., Calles-Escandon J., Sites C. K., Poehlman E. T., Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy Coronary Artery Disease 1998 9 8 503 511
97. Nerbrand C., Nyberg P., Nordstrm L., Samsioe G., Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides Maturitas 2002 42 1 55 62
98. Ma H., Sprecher H. W., Kolattukudy P. E., Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPAR -expressing tissue Journal of Biological Chemistry 1998 273 46 30131 30138
99. Lopez G. N., Webb P., Shinsako J. H., Baxter J. D., Greene G. L., Kushner P. J., Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators Molecular Endocrinology 1999 13 6 897 909
100. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J.-., Unger T., Kintscher U., Metabolic actions of estrogen receptor beta (ER ) are mediated by a negative cross-talk with PPAR PLoS Genetics 2008 4 6
101. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene The EMBO Journal 1992 11 2 433 439